EUS-Guided Choledochoduodenostomy after Failed Endoscopic Retrograde Cholangiopancreatography in Distal Malignant Biliary Obstruction.

IF 1 Q4 GASTROENTEROLOGY & HEPATOLOGY GE Portuguese Journal of Gastroenterology Pub Date : 2023-03-13 eCollection Date: 2023-09-01 DOI:10.1159/000528808
Isabel Tarrio, Marta Moreira, Tarcísio Araújo, Luís Lopes
{"title":"EUS-Guided Choledochoduodenostomy after Failed Endoscopic Retrograde Cholangiopancreatography in Distal Malignant Biliary Obstruction.","authors":"Isabel Tarrio,&nbsp;Marta Moreira,&nbsp;Tarcísio Araújo,&nbsp;Luís Lopes","doi":"10.1159/000528808","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Malignant biliary obstruction drainage is essential, since jaundice is associated with morbidity and mortality. Endoscopic retrograde cholangiopancreatography (ERCP) is the recommended procedure for biliary drainage, with percutaneous biliary drainage being the classic alternative in cases of unsuccessful ERCP. Recently, endoscopic ultrasound-guided biliary drainage has been emerged as a new option, with EUS-guided choledochoduodenostomy (EUS-CDS) being considered an effective and safe method in the drainage of distal obstructions of the common bile duct.</p><p><strong>Aim: </strong>The aim of the study was to evaluate the efficacy and safety of EUS-CDS performed in patients with distal malignant biliary obstructions, after failed ERCP.</p><p><strong>Methods: </strong>Single-center retrospective cohort study between July 2017 and June 2022 including all consecutive patients submitted to EUS-CDS in our center. The primary outcomes were \"technical success\" and \"clinical success,\" defined as \"resolution of jaundice or improvement in total serum bilirubin level above 50% at 7th day and above 75% at 30th day after the procedure.\" Secondary outcomes were procedure-related adverse events, endoscopic reintervention, and survival time.</p><p><strong>Results: </strong>EUS-CDS was performed in 20 patients (65.0% male; median age 76 years). The most frequent etiology for the biliary obstruction was pancreatic adenocarcinoma (<i>n</i> = 17; 85.0%), and most patients presented at advanced stages of cancer (12/60% in stages III or IV). ERCP failure was mainly due to the presence of obstruction in the duodenal lumen (<i>n</i> = 11; 55.0%). Fully covered metallic stents were used in all patients, mostly HotAxios<sup>TM</sup> (<i>n</i> = 15; 75.0%). The technical success rate was 100%, and the clinical success rate was 89.5% (<i>n</i> = 17/19) at 7th day and 93.3% (<i>n</i> = 14/15) at 30th day. Four patients (20.0%) developed cholangitis within the first 30 days after the procedure; there were no late complications, and no patient died as a complication of the procedure. In 2 patients (10.0%), endoscopic reintervention was necessary due to stent migration, incidentally detected. Median survival was 93 days (minimum 5-maximum 751).</p><p><strong>Conclusion: </strong>EUS-CDS was effective in biliary decompression of malignant obstructions of the common bile duct, with high clinical success and a favorable safety profile.</p>","PeriodicalId":51838,"journal":{"name":"GE Portuguese Journal of Gastroenterology","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2023-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/9f/pjg-0030-0065.PMC10561318.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GE Portuguese Journal of Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000528808","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Malignant biliary obstruction drainage is essential, since jaundice is associated with morbidity and mortality. Endoscopic retrograde cholangiopancreatography (ERCP) is the recommended procedure for biliary drainage, with percutaneous biliary drainage being the classic alternative in cases of unsuccessful ERCP. Recently, endoscopic ultrasound-guided biliary drainage has been emerged as a new option, with EUS-guided choledochoduodenostomy (EUS-CDS) being considered an effective and safe method in the drainage of distal obstructions of the common bile duct.

Aim: The aim of the study was to evaluate the efficacy and safety of EUS-CDS performed in patients with distal malignant biliary obstructions, after failed ERCP.

Methods: Single-center retrospective cohort study between July 2017 and June 2022 including all consecutive patients submitted to EUS-CDS in our center. The primary outcomes were "technical success" and "clinical success," defined as "resolution of jaundice or improvement in total serum bilirubin level above 50% at 7th day and above 75% at 30th day after the procedure." Secondary outcomes were procedure-related adverse events, endoscopic reintervention, and survival time.

Results: EUS-CDS was performed in 20 patients (65.0% male; median age 76 years). The most frequent etiology for the biliary obstruction was pancreatic adenocarcinoma (n = 17; 85.0%), and most patients presented at advanced stages of cancer (12/60% in stages III or IV). ERCP failure was mainly due to the presence of obstruction in the duodenal lumen (n = 11; 55.0%). Fully covered metallic stents were used in all patients, mostly HotAxiosTM (n = 15; 75.0%). The technical success rate was 100%, and the clinical success rate was 89.5% (n = 17/19) at 7th day and 93.3% (n = 14/15) at 30th day. Four patients (20.0%) developed cholangitis within the first 30 days after the procedure; there were no late complications, and no patient died as a complication of the procedure. In 2 patients (10.0%), endoscopic reintervention was necessary due to stent migration, incidentally detected. Median survival was 93 days (minimum 5-maximum 751).

Conclusion: EUS-CDS was effective in biliary decompression of malignant obstructions of the common bile duct, with high clinical success and a favorable safety profile.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
内镜逆行胰胆管造影术治疗远端恶性胆道梗阻失败后EUS引导下胆总管十二指肠切开术。
引言:恶性胆道梗阻引流是必不可少的,因为黄疸与发病率和死亡率有关。内窥镜逆行胰胆管造影(ERCP)是胆道引流的推荐方法,经皮胆道引流是ERCP不成功病例的经典选择。近年来,内镜超声引导下胆道引流已成为一种新的选择,EUS引导下胆总管十二指肠切开术(EUS-CDS)被认为是引流胆总管远端梗阻的有效和安全的方法。目的:本研究的目的是评估ERCP失败后,对远端恶性胆道梗阻患者进行EUS-CDS的疗效和安全性。方法:2017年7月至2022年6月的单中心回顾性队列研究,包括我中心所有连续接受EUS-CDS的患者。主要结果是“技术成功”和“临床成功”,定义为“手术后第7天黄疸消退或血清总胆红素水平改善50%以上,第30天改善75%以上”。次要结果是与手术相关的不良事件、内镜再干预和生存时间。结果:20名患者(65.0%为男性;中位年龄76岁)进行了EUS-CDS。胆道梗阻最常见的病因是胰腺癌(n=17;85.0%),大多数患者出现在癌症晚期(12/60%出现在III或IV期)。ERCP失败主要是由于十二指肠腔内存在梗阻(n=11;55.0%)。所有患者均使用全覆盖金属支架,主要是HotAxiosTM(n=15;75.0%)。技术成功率为100%,临床成功率为89.5%(n=17/19),第7天和第30天分别为93.3%(n=14/15)。4名患者(20.0%)在手术后的前30天内出现胆管炎;没有晚期并发症,也没有患者因手术并发症而死亡。在2名患者(10.0%)中,由于偶然发现支架移位,需要进行内窥镜再干预。中位生存期为93天(最少5天,最多751天)。结论:EUS-CDS在胆总管恶性梗阻的胆道减压中是有效的,具有较高的临床成功率和良好的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
GE Portuguese Journal of Gastroenterology
GE Portuguese Journal of Gastroenterology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
1.60
自引率
11.10%
发文量
62
审稿时长
21 weeks
期刊介绍: The ''GE Portuguese Journal of Gastroenterology'' (formerly Jornal Português de Gastrenterologia), founded in 1994, is the official publication of Sociedade Portuguesa de Gastrenterologia (Portuguese Society of Gastroenterology), Sociedade Portuguesa de Endoscopia Digestiva (Portuguese Society of Digestive Endoscopy) and Associação Portuguesa para o Estudo do Fígado (Portuguese Association for the Study of the Liver). The journal publishes clinical and basic research articles on Gastroenterology, Digestive Endoscopy, Hepatology and related topics. Review articles, clinical case studies, images, letters to the editor and other articles such as recommendations or papers on gastroenterology clinical practice are also considered. Only articles written in English are accepted.
期刊最新文献
Portuguese Pancreatic Club Perspectives on Pancreatic Neuroendocrine Neoplasms: Diagnosis and Staging, Associated Genetic Syndromes and Particularities of Their Clinical Approach. Lower Gastrointestinal Bleeding after Gynecological Surgery: An Atypical Endoscopic Diagnosis. Portuguese Pancreatic Club Perspectives on Endoscopic Ultrasound-Guided and Surgical Treatment of Pancreatic Neuroendocrine Tumors Schwannoma of Common Bile Duct: A Clinico-Radiologic Diagnostic Quagmire – A Case Report Endoscopic Mucosal Resection Using Band Ligation of a Duodenal Neuroendocrine Tumor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1